Back
Alnylam Pharmaceuticals Vs. Eli Lilly and Industry Stock Comparison
Sell
15
ALNY
Alnylam Pharmaceuticals
Last Price:
246.59
Seasonality Move:
6.72%
Sell
47
LLY
Eli Lilly and
Last Price:
903.14
Seasonality Move:
3.31%
Sell
15
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $246.78. The Score for ALNY is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
47
Eli Lilly and (LLY)
is a Sell
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $902.71. The Score for LLY is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- LLY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $246.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $902.71
The current trend is moderately bearish and LLY is experiencing slight selling pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.98 | Buy |
| Relative Strength Index (14 RSI): | 39.94 | Sell |
| Chaikin Money Flow: | -378372 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (258.04 - 277.96) | Sell |
| Bollinger Bands (100): | (152.5 - 260.08) | Buy |
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 15.62 | Buy |
| Relative Strength Index (14 RSI): | 46.67 | Sell |
| Chaikin Money Flow: | -1474149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (847.43 - 965.61) | Sell |
| Bollinger Bands (100): | (777.42 - 921.02) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 264.46 | Sell |
| 20-day SMA: | 268.49 | Sell |
| 50-day SMA: | 256.91 | Sell |
| 200-day SMA: | 187.09 | Buy |
| 8-day EMA: | 259.34 | Sell |
| 20-day EMA: | 263.1 | Sell |
| 50-day EMA: | 247.85 | Sell |
| 200-day EMA: | 202.56 | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 940.24 | Sell |
| 20-day SMA: | 933.63 | Sell |
| 50-day SMA: | 895.05 | Buy |
| 200-day SMA: | 765.65 | Buy |
| 8-day EMA: | 931.83 | Sell |
| 20-day EMA: | 922.56 | Sell |
| 50-day EMA: | 894.06 | Buy |
| 200-day EMA: | 775.56 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $4.62 per share, an increase next quarter of $1.15 per share, an increase this year of $10.06 per share, and an increase next year of $6.10 per share.
Alnylam Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eli Lilly and Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||